- Home
- ORGO vs SLDB Comparison
ORGO vs SLDB Comparison
Compare ORGO & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- SLDB
- Stock Information
- Founded
- ORGO 1985
- SLDB 2013
- Country
- ORGO United States
- SLDB United States
- Employees
- ORGO N/A
- SLDB N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORGO Health Care
- SLDB Health Care
- Exchange
- ORGO Nasdaq
- SLDB Nasdaq
- Market Cap
- ORGO 465.6M
- SLDB 529.4M
- IPO Year
- ORGO N/A
- SLDB 2018
- Fundamental
- Price
- ORGO $4.89
- SLDB $5.93
- Analyst Decision
- ORGO Buy
- SLDB Strong Buy
- Analyst Count
- ORGO 2
- SLDB 10
- Target Price
- ORGO $7.50
- SLDB $15.00
- AVG Volume (30 Days)
- ORGO 642.5K
- SLDB 1.1M
- Earning Date
- ORGO 08-07-2025
- SLDB 08-12-2025
- Dividend Yield
- ORGO N/A
- SLDB N/A
- EPS Growth
- ORGO N/A
- SLDB N/A
- EPS
- ORGO N/A
- SLDB N/A
- Revenue
- ORGO $429,531,000.00
- SLDB N/A
- Revenue This Year
- ORGO $2.57
- SLDB N/A
- Revenue Next Year
- ORGO $9.80
- SLDB N/A
- P/E Ratio
- ORGO N/A
- SLDB N/A
- Revenue Growth
- ORGO N/A
- SLDB N/A
- 52 Week Low
- ORGO $2.46
- SLDB $2.41
- 52 Week High
- ORGO $6.71
- SLDB $10.11
- Technical
- Relative Strength Index (RSI)
- ORGO 59.08
- SLDB 47.64
- Support Level
- ORGO $4.41
- SLDB $5.46
- Resistance Level
- ORGO $4.90
- SLDB $6.28
- Average True Range (ATR)
- ORGO 0.30
- SLDB 0.40
- MACD
- ORGO -0.03
- SLDB -0.14
- Stochastic Oscillator
- ORGO 92.58
- SLDB 32.32
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.